Supplementary Figures 1-6 from The Multikinase Inhibitor Sorafenib Potentiates TRAIL Lethality in Human Leukemia Cells in Association with Mcl-1 and cFLIPL Down-regulation
Open Access
- 30 March 2023
- other
- Published by American Association for Cancer Research (AACR)
Abstract
Supplementary Figures 1-6 from The Multikinase Inhibitor Sorafenib Potentiates TRAIL Lethality in Human Leukemia Cells in Association with Mcl-1 and cFLIPL Down-regulationKeywords
This publication has 0 references indexed in Scilit: